Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahul Subhash Buchade

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Drug Research Reviews|April 25, 2025
Diabetic Wound Healing: Mechanism and Treatment Strategies with a Special Focus on AngiogenesisAnkita Wal, Nidhi Singh, Pranay Wal, et al.
Current Gene Therapy|June 11, 2024
Acetylresveratrol (AC-Res): An Evolving Frontier in Modulating Gene ExpressionUttam Prasad Panigrahy, Rahul Subhash Buchade, Sandhya Subhadra, et al.
Plos One|January 19, 2023
Wheat ergot fungus-derived and modified drug for inhibition of intracranial aneurysm rupture due to dysfunction of TLR-4 receptor in Alzheimer's diseaseSandip Debnath, Devesh Sharma, Somdatta Yashwant Chaudhari, et al.
Frontiers in Molecular Neuroscience|December 23, 2022
Recognizing novel drugs against Keap1 in Alzheimer's disease using machine learning grounded computational studiesNobendu Mukerjee, Khattab Al-Khafaji, Swastika Maitra, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Drug Research Reviews|April 25, 2025
Diabetic Wound Healing: Mechanism and Treatment Strategies with a Special Focus on AngiogenesisAnkita Wal, Nidhi Singh, Pranay Wal, et al.
Current Gene Therapy|June 11, 2024
Acetylresveratrol (AC-Res): An Evolving Frontier in Modulating Gene ExpressionUttam Prasad Panigrahy, Rahul Subhash Buchade, Sandhya Subhadra, et al.
Plos One|January 19, 2023
Wheat ergot fungus-derived and modified drug for inhibition of intracranial aneurysm rupture due to dysfunction of TLR-4 receptor in Alzheimer's diseaseSandip Debnath, Devesh Sharma, Somdatta Yashwant Chaudhari, et al.
Frontiers in Molecular Neuroscience|December 23, 2022
Recognizing novel drugs against Keap1 in Alzheimer's disease using machine learning grounded computational studiesNobendu Mukerjee, Khattab Al-Khafaji, Swastika Maitra, et al.
Pageof 1